In vitro digestion and fermentation of 5-formyl-aminosailcylate-inulin: A potential prodrug of 5-aminosalicylic acid

Bioactive Carbohydrates and Dietary Fibre

Volumn 2, Issue 1, 2013, Pages 8-14

  Hartzell, Annette L ^a,b   Maldonado Gómez, María X ^a   Yang, Junyi ^a   Hutkins, Robert W ^a   Rose, Devin J ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

5 aminosalicylic acid; Drug delivery; Fermentation; Inflammatory bowel disease; Mesalamine; Prebiotic

Indexed keywords

5 FORMYL AMINOSAILCYLATE INULIN; A 3537; AMINOSALICYLIC ACID; BUTYRIC ACID; CARBOHYDRATE; INULIN; PRODRUG; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DESCENDING COLON; DRUG CONJUGATION; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG METABOLISM; DRUG SYNTHESIS; ESTERIFICATION; FECES MICROFLORA; IN VITRO STUDY; INTESTINE FLORA; PRIORITY JOURNAL;

EID: 84886703552     PISSN: 22126198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcdf.2013.08.001     Document Type: Article

References (39)

1. S. Al-Lahham, H. Roelofsen, F. Rezaee, D. Weening, A. Hoek, and R. Vonk Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects European Journal of Clinical Investigation 42 2012 357 364
2. J.L. Benjamin, C.R.H. Hedin, A. Koutsoumpas, S.C. Ng, N.E. McCarthy, and A.L. Hart Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn′s disease Gut 60 2011 923 929
3. D. Bentley, A.M. Young, L. Rowell, G. Gross, J. Tardio, and D. Carlile Evidence of a drug-drug interaction linked to inhibition of ester hydrolysis by Orlistat Journal of Cardiovascular Pharmacology 60 2012 390 396
4. H. Both, K. Torp-Pedersen, S. Kreiner, C. Hendriksen, and V. Binder Clinical-appearance at diagnosis of ulcerative-colitis and Crohn′s disease in a regional patient group Scandinavian Journal of Gastroenterology 18 1983 987 991 (Pubitemid 13014828)
5. Y. Bouhnik, L. Raskine, G. Simoneau, E. Vicaut, C. Neut, B. Flourie, and F. Brouns The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study American Journal of Clinical Nutrition 80 2004 1658 1664 (Pubitemid 41103868)
6. R. Caprilli, M. Cesarini, E. Angelucci, and G. Frieri The long journey of salicylates in ulcerative colitis: The past and the future Journal of Crohn′s & Colitis 3 2009 149 156
7. F. Casellas, N. Borruel, A. Torrejón, E. Varela, M. Antolin, F. Guarner, and J.R. Malagelada Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin Alimentary Pharmacology & Therapeutics 25 2007 1061 1067 (Pubitemid 46587689)
8. V. De Preter, I. Arijs, K. Windey, W. Vanhove, S. Vermeire, and F. Schuit Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis Inflammatory Bowel Diseases 18 2012 2371 2380
9. M. Dubois, K.A. Gilles, J.K. Hamilton, P.A. Rebers, and F. Smith Colorimetric method for determination of sugars and related substances Analytical Chemistry 28 1956 350 356
10. S.H. Duncan, K.P. Scott, A.G. Ramsay, H.J.M. Harmsen, G.W. Welling, and C.S. Stewart Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system Applied and Environmental Microbiology 69 2003 1136 1142 (Pubitemid 36204845)
11. T.A. Faber, and G.C. Fahey Jr. Animal, in vitro, and cell culture models to study the role of dietary fibers in the gastrointestinal tract of humans T.M. Paeschke, W.R. Aimutis, Nondigestible carbohydrates and digestive health 2011 Wiley-Blackwell Ames, IA 97 124
12. J.W. Faigle Drug metabolism in the colon wall and lumen P.R. Bieck, Colonic drug absorption and metabolism 1993 Marcel Dekker New York 29 54 (1993)
13. T. Fujimoto, H. Imaeda, K. Takahashi, E. Kasumi, S. Bamba, and Y. Fujiyama Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn′s disease Journal of Gastroenterology and Hepatology 28 2013 613 619
14. G.R. Gibson, H.M. Probert, J. van Loo, R.A. Rastall, and M.B. Roberfroid Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics Nutrition Research Reviews 17 2004 259 275
15. A. Gulbake, and S.K. Jain Chitosan: A potential polymer for colon-specific drug delivery system Expert Opinion on Drug Delivery 9 2012 713 729
16. H.M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F.J. Troost, and R.J. Brummer Review article: The role of butyrate on colonic function Alimentary Pharmacology & Therapeutics 27 2008 104 119 (Pubitemid 350256609)
17. S.B. Hanauer Review article: Aminosalicylates in inflammatory bowel disease Alimentary Pharmacology & Therapeutics 20 2004 60 65 (Pubitemid 39319249)
18. A.L. Hartzell, M.X. Maldonado-Gómez, R.W. Hutkins, and D.J. Rose Synthesis and in vitro digestion and fermentation of acylated inulin Bioactive Carbohydrates and Dietary Fibre 1 2013 81 88
19. M.S. Inan, R.J. Rasoulpour, L. Yin, A.K. Hubbard, D.W. Rosenberg, and C. Giardina The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line Gastroenterology 118 2000 724 734 (Pubitemid 30171622)
20. Y.J. Jung, J.S. Lee, H.H. Kim, Y.T. Kim, and Y.M. Kim Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid Archives of Pharmacal Research 21 1998 179 186 (Pubitemid 128660994)
21. H.J. Lee, H. Zhang, D.A. Orlovich, and J.P. Fawcett The influence of probiotic treatment on sulfasalazine metabolism in rat Xenobiotica 42 2012 791 797
22. C.H.M. Leenen, and L.A. Dieleman Inulin and oligofructose in chronic inflammatory bowel disease Journal of Nutrition 137 2007 2572S 2575S (Pubitemid 350058738)
23. J.O. Lindsay, K. Whelan, A.J. Stagg, P. Gobin, H.O. Al-Hassi, and N. Rayment Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn′s disease Gut 55 2006 348 355 (Pubitemid 43268272)
24. S. Macfarlane, G.T. Macfarlane, and J.H. Cummings Review article: Prebiotics in the gastrointestinal tract Alimentary Pharmacology & Therapautics 24 2006 701 714
25. O.H. Nielsen, and S. Bondesen Kinetics of 5-aminosalicylic acid after jejunal installation in man British Journal of Clinical Pharmacology 16 1983 738 740 (Pubitemid 14208220)
26. M.T. Osterman, and G.R. Lichtenstein Reformulation of an aminosalicylate: An example of the importance of pill burden on medical compliance rates Methods and Findings in Experimental and Clinical Pharmacology 31 2009 41 46
27. E. Pastorini, M. Locatelli, P. Simoni, G. Roda, E. Roda, and A. Roda Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma Journal of Chromatography B 872 2008 99 106
28. M.M. Patel, and A.F. Amin Recent trends in microbially and/or enzymatically driven colon-specific drug delivery systems Critical Reviews in Therapeutic Drug Carrier Systems 28 2011 489 552 (d)
29. M. Rajilic-Stojanovic, F. Shanahan, F. Guarner, and W.M. de Vos Phylogenetic analysis of dysbiosis in ulcerative colitis during remission Inflammatory Bowel Diseases 19 2013 481 488
30. M. Roberfroid, G.R. Gibson, L. Hoyles, A.L. McCartney, R. Rastall, and I. Rowland Prebiotic effects: Metabolic and health benefits British Journal of Nutrition 104 2010 S1 S63
31. W.E. Roediger Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man Gut 21 1980 793 798 (Pubitemid 11209227)
32. J.P. Segain, B.D. de la Raingeard, A. Bourreille, V. Leray, N. Gervois, and C. Rosales Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn′s disease Gut 47 2000 397 403
33. N. Shah, T. Shah, and A. Amin Polysaccharides: A targeting strategy for colonic drug delivery Expert Opinion on Drug Delivery 8 2011 779 796
34. R.K. Shukla, and A. Tiwari Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon Carbohydrate Polymers 88 2012 399 416
35. P. Sriamornsak Application of pectin in oral drug delivery Expert Opinion on Drug Delivery 8 2011 1009 1023
36. J. Varshosaz Dextran conjugates in drug delivery Expert Opinion on Drug Delivery 9 2012 509 523
37. W. Vollmer, B. Joris, P. Charlier, and S. Foster Bacterial peptidoglycan (murein) hydrolases FEMS Microbiology Reviews 32 2008 259 286 (Pubitemid 351257818)
38. C.F. Welters, E. Heineman, F.B. Thunnissen, A.E. van den Bogaard, P.B. Soeters, and C.G. Baeten Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis Diseases of the Colon & Rectum 45 2002 621 627 (Pubitemid 34507237)
39. M. Zou, H. Okamoto, G. Cheng, X. Hao, J. Sun, F. Cui, and K. Danjo Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems European Journal of Pharmaceutics and Biopharmaceutics 59 2005 155 160 (Pubitemid 39573448)